Ashley Black
ablack@elixirmedical.com
Elixir Medical is committed to transforming care of patients with heart and vascular disease through innovation.
Since 2005, the company has continually sought to improve the treatment of vascular disease with:
- Drug-eluting coronary stent systems (DES)
- Fully resorbable drug-eluting scaffold systems (BRS)
- Drug-eluting coronary bioadaptor systems
Its latest innovation — the DynamX™ Coronary Bioadaptor System — is designed to be a significant advancement beyond drug-eluting stents (DES).
Elixir Medical’s innovations are designed to make a meaningful change in patients’ lives. The company does not simply want to engineer a better medical device. Saving lives and helping patients enjoy their daily life is what drives us every day.
Since 2005, the company has continually sought to improve the treatment of vascular disease with:
- Drug-eluting coronary stent systems (DES)
- Fully resorbable drug-eluting scaffold systems (BRS)
- Drug-eluting coronary bioadaptor systems
Its latest innovation — the DynamX™ Coronary Bioadaptor System — is designed to be a significant advancement beyond drug-eluting stents (DES).
Elixir Medical’s innovations are designed to make a meaningful change in patients’ lives. The company does not simply want to engineer a better medical device. Saving lives and helping patients enjoy their daily life is what drives us every day.
